Paracellular Route: A Target for Drug Delivery

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: closed (10 October 2022) | Viewed by 3706

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmaceutical Technology and Parasitology, Faculty of Pharmacy, University of Valencia, 46100 Burjassot, Valencia, Spain
Interests: intestinal absorption; paracellular route; enhancers; biopharmaceutics; ethanol addiction; pharmacotherapeutic treatment of Alcohol Use Disorders (AUD)

E-Mail Website
Guest Editor
Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, 46010 València, Spain
Interests: intestinal absorption; paracellular route; central nervous system; biopharmaceutics

Special Issue Information

Dear Colleagues,

The paracellular pathway has gained great importance in recent decades thanks in part to the wider knowledge of its structure and control of its functions, both at the intestinal and at the blood–brain barrier (BBB) level. Furthermore, it is already considered an ideal route for oral absorption of medium-sized hydrophilic drugs, sometimes thanks to the use of absorption enhancers in different formulations. In this issue, our aim is to present recent research on the use of new enhancers for intestinal absorption by this route, including aspects of the mechanism of action, toxicity, whether the effects are reversible upon the intestinal barrier function, and lastly, use of enhancers in intestinal absorption in vitro models and extrapolation in in vivo models. Alternatively, the latest research on the opening of paracellular junctions at the BBB level will also be considered, since it constitutes an important route of access of several drugs to the central nervous system. Lastly, it will be considered the analysis of the injury provoked by disruptors at paracellular level.

Prof. Dr. Ana Polache
Dr. María José Cano-Cebrián
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • paracellular route
  • barrier function
  • barrier disruptors
  • absorption enhancement

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

38 pages, 7325 KiB  
Review
Current Update on Transcellular Brain Drug Delivery
by Bhakti Pawar, Nupur Vasdev, Tanisha Gupta, Mahi Mhatre, Anand More, Neelima Anup and Rakesh Kumar Tekade
Pharmaceutics 2022, 14(12), 2719; https://0-doi-org.brum.beds.ac.uk/10.3390/pharmaceutics14122719 - 05 Dec 2022
Cited by 8 | Viewed by 2871
Abstract
It is well known that the presence of a blood–brain barrier (BBB) makes drug delivery to the brain more challenging. There are various mechanistic routes through which therapeutic molecules travel and deliver the drug across the BBB. Among all the routes, the transcellular [...] Read more.
It is well known that the presence of a blood–brain barrier (BBB) makes drug delivery to the brain more challenging. There are various mechanistic routes through which therapeutic molecules travel and deliver the drug across the BBB. Among all the routes, the transcellular route is widely explored to deliver therapeutics. Advances in nanotechnology have encouraged scientists to develop novel formulations for brain drug delivery. In this article, we have broadly discussed the BBB as a limitation for brain drug delivery and ways to solve it using novel techniques such as nanomedicine, nose-to-brain drug delivery, and peptide as a drug delivery carrier. In addition, the article will help to understand the different factors governing the permeability of the BBB, as well as various formulation-related factors and the body clearance of the drug delivered into the brain. Full article
(This article belongs to the Special Issue Paracellular Route: A Target for Drug Delivery)
Show Figures

Figure 1

Back to TopTop